Pneumovax-23, Injektionslösung in einer Fertigspritze

7680656750035 CH-65675 Injektionslösung
Pneumovax-23, Injektionslösung in einer Fertigspritze
Pneumovax-23, Injektionslösung in einer Fertigspritze
Pneumovax-23, Injektionslösung in einer Fertigspritze
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
20/01/2023
Summary of Product Characteristics
Français
20/01/2023
Summary of Product Characteristics
Italien
20/01/2023

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
25.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
1.8 MG Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 37.35
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2021

Authorization holder

MSD Merck Sharp & Dohme AG

6005 Luzern

Authorization information

Swissmedic authorization number
65675
Drug name
Pneumovax-23, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
J07AL01
Authorization status
Z
Dispensing category
B
First authorization
26/02/2016
Authorization expiration date
31/12/9999
IT Number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Pneumokokken-Infektionen, insbesondere Pneumonien, ab dem vollendeten 2. Lebensjahr

Package details

Description (FR)
PNEUMOVAX 23 sol inj 1 pce
Description (DE)
PNEUMOVAX 23 Inj Lös 1 Stk
Market launch
26/02/2016
Narcotic (BTM)
No

Other package sizes (3)

None
None None
GTIN: None
Not in V1
None
None None
GTIN: None
Not in V1
PNEUMOVAX 23 sol inj 10 pce
10 FESP
GTIN: 7680656750042
View